# Divinity

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/divinity

- Industry: Biotechnology
- Headquarters: Bozhou, China
- Website: www.ahdivinity.com
- Latest round: Series A (Jul 10, 2014)
- Investors on record: 1

## About

Established in 2010 and based in Bozhou, China, Divinity operates as a biopharmaceutical company dedicated to providing biological vaccines for veterinary and poultry. It has R&D and marketing companies in Beijing, Guangzhou, and Anhui. The company acquired certifications such as ISO14001, ISO45001, and ISO9001, and has obtained 10 patents. In July 2014, it closed series A funding from new investor GF Venture Capital. In April 2016, Anhui Divinity Biological Products Co., Ltd. was listed on the New Third Board (NEEQ).

The company mainly provides animal vaccines. It provides three product lines, which are animal vaccines, poultry vaccines, and cattle and sheep vaccines. The main products of the company are pseudorabies live vaccine with heat-resistant protectant, viral gastrointestinal bivalent inactivated vaccine, and highly pathogenic porcine reproductive and respiratory syndrome blue ear disease live vaccine.

The company generates revenue by providing animal vaccines, poultry vaccines, and cattle and sheep vaccines.

## Funding rounds

- Series A, Jul 10, 2014 — GF Venture Capital

## Investors

- GF Venture Capital (https://capitalatlas.ai/funds/gf-venture-capital) — Series A